Lenacapavir, the first twice-yearly HIV prophylactic in the world, is set to be rolled out in Zimbabwe, one of 10 countries ...

SINCE the 1980s, researchers have worked tirelessly to develop effective treatments that can suppress the HIV virus to undetectable levels. As a result, by taking a single daily dose of an ...

MSD’s investigational two-drug HIV combination has been proven safe, efficacious and non-inferior to current standard of care ...

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as antiretroviral therapy (ART), are highly effective at suppressing the virus and ...

Older adults living with HIV face higher rates of opioid prescribing and opioid use disorder than their HIV-negative peers, according to new research from Rutgers University.

New EACS 2025 data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance ...

A simple search on Google can lead to panic and misinformation when it comes to health. Discover why turning to your ...

Zimbabwe is among 10 nations rolling out lenacapavir, a twice-yearly HIV prevention shot. Experts call it a breakthrough, but ...

Dairy products like milk, cheese, and yogurt may interact with certain medications, making them less effective. Avoid dairy products with certain antibiotics.

Scientists are nearing a breakthrough in using CRISPR gene-editing to eliminate HIV from human DNA. Early trials of EBT-101 ...